Bunge Global SA

source: coverage-next-full ticker: BG step: 01 title: Business Model (Overview) date: 2026-05-28

Step 01 — Business Model

Key Findings

• What BG does (one line): Bunge Global is the world's largest oilseed processor by capacity and, post-Viterra, one of the four dominant global grain merchants, monetizing the spread between farmer-origination prices and downstream food/feed/fuel demand [S1][S2].
• Operating model is dual-layer: (1) an asset-heavy industrial business — crush plants, port elevators, refineries — earning margin on physical throughput; (2) a commercial trading book — origination basis, freight, futures, and biofuel arbitrage — that can swing quarterly EBIT by hundreds of millions [S3].
• Four reporting segments post-Viterra (effective Q3 2025): Soybean Processing & Refining, Softseed Processing & Refining, Tropical Oils & Specialty Ingredients, Grain Merchandising & Milling [S4]. Q1 2026 segment Adj EBIT contribution was 57%/30%/7%/7% respectively — heavily soybean-led.
• Value-chain position: BG sits in layers 1-4 (origination, logistics, processing, refining); it does not operate downstream branded consumer foods (unlike ADM Nutrition or Cargill's specialty ingredient lines), nor upstream farm ownership [S5].
• Net read: MIXED-POSITIVE for thesis. Scale is now unmatched globally in oilseed processing; the strategic gap vs ADM is the lighter downstream specialty footprint. Bull case: synergies + biofuel pull-through. Bear case: commodity-cycle exposure with diluted equity base.

Implications for Thesis and Valuation

• BG is fundamentally a spread business, not a fee/recurring-revenue model. Valuation framework must accept cyclical earnings.
• The post-Viterra entity is more grain-merchandising-tilted than the standalone Bunge of 2019-2024 — closer in shape to ADM than to a pure crushing comp.
• The biggest valuation lever is the next-3-years average mid-cycle crush margin assumption (highly sensitive — modeled in Step 14 of /complete-coverage).
• BG's earnings are NOT linear / extrapolable from any single year; CY2023 was a high-margin year ($14.87 GAAP EPS), CY2024 was trough ($7.99), CY2025 reported ($4.91 GAAP / $7.57 adj) reflects integration drag.

Objective

Describe what Bunge does in plain language, map its value-chain position, identify revenue streams and economics, document the segment structure post-Viterra, and frame the operating-vs-trading split that drives quarterly variance.

Narrative Analysis

What BG actually does

In any given month, Bunge:

1. Buys raw oilseeds (mostly soybeans, canola, sunflower seed) and grains (wheat, corn) from farmers in Brazil, Argentina, US Midwest, Canada, EU, Black Sea, and Australia — increasingly so via Viterra's elevator network.
2. Moves them via owned-and-leased port terminals, river barges, rail, and trucks — the logistical optimization across origin/destination pairs being one of the trading book's main P&L levers.
3. Crushes oilseeds into vegetable oil + protein meal at ~75-80 plants worldwide.
4. Refines crude vegetable oil into branded/private-label cooking oils, bottled oils, margarine bases, biofuel feedstock.
5. Mills wheat and corn into flour and dry-mill products.
6. Sells to: food manufacturers (Nestle, Unilever, P&G's food brands, Procter & Gamble, Cargill itself for further processing), animal feed mills, foodservice distributors, biofuel producers (Chevron under the JV, plus arm's-length sales to Phillips 66, Marathon, Valero), and end-customers via private-label oils [S1].

Layered value-chain map

Layer 1: Origination — farmer-facing, basis-pricing
   ↓ (Bunge legacy: light; Viterra: heavy)
Layer 2: Logistics — port elevators, river/rail/truck, storage
   ↓ (Bunge + Viterra combined)
Layer 3: Processing — crush plants (oilseeds), mills (wheat/corn)
   ↓ (Bunge core competency, largest globally post-Viterra)
Layer 4: Refining & Distribution — refined oils, lecithin, specialty ingredients
   ↓ (Bunge: present; ADM: deeper)
Layer 5: Branded Consumer / Specialty — NOT operated by BG

[S1][S5]

Revenue streams

BG's segment structure post-Viterra (effective Q3 2025) [S4]:

[S4]

Operating-vs-trading split

A single Q1 reading suggests that BG's processing segments earn ~3-5% segment Adj EBIT margins from physical throughput, while the Grain Merchandising & Milling segment runs at ~0-1% margin most of the time because it's effectively a flow business: high revenue (port + elevator + trading throughput), low fixed margin per ton, with EBIT swinging when basis spreads or freight arbs open up. This is a fundamental difference from pure-play food companies — BG's trading book is a real risk and earnings line, not back-office hedging [S6].

The Chevron JV (Bunge Chevron Ag Renewables)

50/50 joint venture with Chevron. Bunge contributed soybean processing facilities in Destrehan, LA and Cairo, IL; Chevron contributed ~$600M cash. Capacity goal: expand from 7,000 tons/day (end 2024) to ~14,000 tons/day by end 2026. Sells low-CI soybean oil to Chevron's renewable diesel refineries. This is equity-method consolidation (not part of BG's reported revenue), but it is a strategic optionality on US biofuel mandates [S7]. Secondary track applies here: this asset is best valued via standard DCF / capacity multiples, not commodity-cycle logic.

What BG is NOT

• Not a branded consumer foods company (no Mazola/Wesson equivalent at scale within BG; some specialty oils are branded but small)
• Not an agronomy / seed company (no equivalent to Corteva or Bayer Crop Science)
• Not a fertilizer or crop protection player
• Not vertically integrated upstream into farm operations

This shapes the moat assessment: BG's moat — if any — is in scale, geographic optionality, and trading book skill, not in IP or brand. (Tested in Step 10.)

Evidence and Sources

• Segment structure and Q1 2026 segment Adj EBIT: company Q1 2026 press release [S4]
• Value-chain position vs ADM: peer comparison and industry analysis [S5]
• Chevron JV mechanics and capacity: 2023 biodieselmagazine + biofuels-news coverage [S7]
• General BG description and post-Viterra commentary [S1][S2][S3]

Assumption Register Updates

Tables and Calculations

Segment Mix — Q1 2026 (one-quarter sample)

Historic Segment Structure (pre-Q3 2025)

Pre-realignment, Bunge reported as: Agribusiness, Refined & Specialty Oils, Milling, Sugar & Bioenergy. The realignment in Q3 2025 was driven by the Viterra integration and management's combined-company operating view. Direct comparability for full-year segment series will require restating prior periods — pending in /complete-coverage Step 13 work.

Open Questions and Data Gaps

• Sugar & Bioenergy segment treatment under new 4-segment structure (likely embedded into Grain Merchandising or treated as held-for-sale separately) — to confirm from 10-K segment note
• Customer concentration explicit disclosure
• Geographic mix split by segment (especially South America vs North America)
• Full-year FY2025 segment data not transcribed (only summary press release fragments)

Next-Step Dependencies

• Step 02 will use segment structure here for industry/market positioning
• Step 03 will need segment-level margin data for margin tree
• Step 10 will test moat hypothesis using value-chain map

Source Index

source: coverage-next-full ticker: BG step: 12 title: Bull vs Bear (Catalysts) date: 2026-05-28

Step 12 — Bull / Bear Debate (Catalysts)

No transcripts used. Following the skill's spec for the non-transcript path, the bull/bear analyst debate is inferred from consensus notes, press releases, recent news, the FY26 guidance trajectory, and the segment-level Q1 2026 print rather than full earnings-call discussion.

Key Findings

• The Street is consensus bullish — 9 reporting analysts with 5 Strong Buy / 3 Buy / 1 Hold / 0 Sell; average price target $142 (15% upside) [S1].
• The bull case rests on three legs: (1) Viterra synergy realization on the announced cadence, (2) crush margin recovery as RVO biofuel policy clarifies, (3) deleveraging path restoring earnings quality.
• The bear case rests on three legs: (1) cycle risk — soybean / vegetable oil prices remain depressed if RVO disappoints, (2) integration drag persists longer than guided, (3) overlevered balance sheet constrains growth + dividend / buyback ability.
• The valuation level (~13x forward EPS) is the swing factor — it's below historical avg ~15x but above peer ADM (~10x), reflecting Viterra-execution optimism. If FY26 prints ~$9.50 Adj EPS and FY27 prints $11+, the multiple expands further; if FY26 disappoints, it compresses sharply.
• Q1 2026 print itself was the clearest catalyst — +89% beat vs consensus + guidance raise from $7.50-8.00 to $9.00-9.50 drove the stock from ~$95 (early April) to $124 (late May).
• Net read: TILT BULLISH NEAR-TERM, BALANCED MEDIUM-TERM. Q1 print + guidance raise are real positives; the remaining 2026 quarters need to confirm the trajectory.

Implications for Thesis and Valuation

• The bull case is in the price at $124 with consensus FY26 at $9.62 and FY27 at $11.26 (~10-11x forward — already below historical multiple)
• For the stock to materially appreciate from here ($150+ target), FY27 needs to exceed $11.50 + multiple stays at 12-13x = $138-150
• For the stock to materially decline from here ($95 area), one of: RVO disappoints + crush margin fades, integration cost overrun, leverage credit-rating action

Objective

Frame the bull and bear theses with quantified upside/downside scenarios, identify near-term catalysts that can move the stock, and document thesis-invalidators.

Narrative Analysis

The Bull Thesis (synthesizing the optimistic case from Q1 2026 print + Street consensus + management messaging)

Core argument: BG is at an inflection point. The Viterra integration is delivering ahead of schedule ($70M synergies realized 2025, $190M targeted 2026, $220M run-rate target). Crush margins are recovering from cycle trough (+56% YoY in soybean processing Q1 2026). The combined entity is structurally stronger than pre-merger BG. FY27 EPS power of $11-12+ is achievable at the right cycle.

Supporting points (per consensus analyst commentary):

• 5 Strong Buy ratings; average price target $142 (+15% vs $123.83)
• Median target $145 (+17%); high target $150 (+21%)
• Q1 2026 beat consensus by 89% on Adj EPS
• Mgmt raised FY26 guidance from $7.50-8.00 to $9.00-9.50 — material upward revision
• 14 analysts covering — broad institutional interest
• Forward P/E of 12.16 vs historical avg ~15x → multiple expansion available if earnings deliver
• Segment-level signals: Soybean P&R +56% YoY, Softseed +138%, Tropical +96% in Q1
• Synergy capture pace tracking ahead of management's own initial trajectory

Quantified bull case (price target $150 / +21%):

• FY27 Adj EPS: $11.50 (above consensus $11.26)
• Multiple: 13x forward (premium to ADM's ~10x reflecting Viterra synergy + biofuel optionality)
• = $149-150 fair value
• ROIC recovers to ~10% (above WACC)
• Deleveraging on track to <3.0x by end-2027
• Glencore lockup releases without overhang

[S1][S2][S3]

The Bear Thesis (synthesizing the bearish counterpoints)

Core argument: The Viterra deal was expensive at 8.5x pre-synergy EBITDA, dilutive (33% more shares), and the path to value-accretion requires multi-year flawless execution. The 2025-2026 commodity environment was unusually weak (soybean oil glut, China-US trade disruption, biofuel policy uncertainty), and there's no guarantee 2026-2028 will be materially better. Leverage is elevated; if anything goes wrong, BG has limited ability to deploy capital defensively.

Supporting points:

• 1 Hold rating in current coverage; no Sell ratings (but the "Hold" matters)
• Forward P/E of 12 is not particularly cheap on a forward earnings number that itself depends on optimistic synergy + margin assumptions
• ROIC currently 3.5% — well below WACC; even FY27E forecast (~8.8%) is barely above
• Net debt $14B; rating-agency action a watch-item
• Buyback runway constrained near-term (~$300M/yr vs $1.1B in FY24)
• ADM's 81% crushing EBIT collapse in FY25 shows what a hostile biofuel policy environment does to the segment
• Brazilian oversupply + Argentine peso volatility create chronic margin pressure
• Glencore monetization risk post-lockup (early 2027)
• Climate change is a long-term structural risk for South American agriculture

Quantified bear case (price target $95 / -23%):

• FY27 Adj EPS: $8.50 (below consensus $11.26 — synergies underdeliver, crush margins flat)
• Multiple: 11x forward (further compression on disappointed expectations)
• = $93-95 fair value
• Possible rating downgrade if deleveraging slips
• Dividend cut not likely but buybacks pause

[S1][S2]

Near-Term Catalysts (next 12 months)

Thesis Invalidators

The thesis is invalidated (i.e., long becomes sell or short) if any of these materialize:

• FY26 Adj EPS prints below $8.00 (i.e., guidance miss + guidance cut for FY27)
• Net Debt / EBITDA stays above 4.0x through end-2027 (deleveraging stalls)
• Credit rating cut to BB+ / Ba1 (loss of investment grade)
• Viterra integration impairment charge >$1B (synergy thesis broken)
• RVO mandates cut materially in any forthcoming rule
• Major operational accident at a flagship plant or port

What the Q1 2026 Print Told Us

Looking at the Q1 2026 results in this light: 89% beat + guidance raise — that's the strongest possible single-quarter positive signal. It suggests the bull case is currently in the driver's seat. But Q1 is a low-base quarter; the next two prints (Q2 in July 2026, Q3 in October 2026) are what confirm or deny the trajectory.

Evidence and Sources

• Consensus + ratings: Consensus document [S1]
• Q1 + Q4 prints: press releases [S2]
• Synergy & guidance: management commentary [S3]
• Peer (ADM) read-throughs: industry coverage [S4]

Assumption Register Updates

Tables and Calculations

Three-Scenario Fair Value Bridge

Implication: at $124, the stock is roughly fairly valued on probability-weighted basis with a slight upward tilt. The Q1 print + guidance raise have already moved the price into "fair" territory; further upside requires Q2-Q3 confirmation of the trajectory.

Bull Case — 3 bullets

• Viterra synergies ahead of pace — $70M realized in just 6 months of 2025 H2 puts the company on a track to exceed $190M FY26 target and possibly reach $250M+ run-rate by end-2027; each $100M synergy = ~$0.40 EPS uplift.
• Crush margin recovery + biofuel pull-through — Q1 2026 Soybean P&R +56% YoY and Softseed +138% YoY signal cycle inflection; RVO clarity in 2026-2027 could expand soybean oil demand structurally and lift mid-cycle EBIT by $300-500M.
• Combined entity at peak scale + geographic optionality — largest global oilseed processor by capacity, broadest origination footprint, and the Chevron JV embeds free option value on US renewable diesel mandates; mid-cycle ROIC recovery to 10%+ supports $150+ price target on 13x $11.50 FY27 EPS.

Bear Case — 3 bullets

• Cycle + leverage = downside asymmetry — 4.3x current Net Debt / EBITDA combined with cycle-trough ROIC of 3.5% means any negative surprise (RVO disappointment, BRL crash, integration cost overrun) directly threatens dividend / buyback capacity and possibly investment-grade credit rating.
• Viterra dilution requires perfect execution — 33% more shares outstanding mean FY27 EPS of $11+ requires Viterra-combined NOPAT growth of 30%+ vs FY24 standalone — a high bar dependent on synergy realization, crush margin recovery, AND clean integration with no further charges.
• Multiple already pricing optimism — at 12x forward EPS the stock is well above ADM's ~10x; the gap reflects Viterra-execution + biofuel optionality already embedded in the price; bear case multiple compression to 11x on $8.50 FY27 EPS gets to $95, down 23%.

Open Questions and Data Gaps

• Transcript-level management Q&A (intentionally not available; this skill's main blind spot)
• Specific sensitivity disclosures for FY26 (typically given in investor day, March 2026)
• Synergy-by-source breakdown (cost vs revenue)
• 3-year FY27-FY29 medium-term outlook detail

Next-Step Dependencies

• Step 16 will refine the variant-perception view (what the Street is NOT pricing)
• Step 17 will examine institutional / Glencore positioning
• Step 18 will translate this bull/base/bear set into portfolio sizing
• Step 15 (in /complete-coverage) will build out the formal probabilistic scenarios

Source Index